Trade Summary

2 days ago, Loeillot Olivier, serving as Chief Executive Officer at REPLIGEN CORP (RGEN), sold 5,426 shares at $180.00 per share, for a total transaction value of $976,680.00. Following this transaction, Loeillot Olivier now holds 54,246 shares of RGEN.

This sale represents a 9.09% decrease in Loeillot Olivier's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, August 20, 2026 and publicly disclosed via SEC Form 4 filing on Friday, August 21, 2026 at 4:06 PM ET, 1 day after the trade was made.

REPLIGEN CORP operates in the HEALTHCARE sector, specifically within the MEDICAL INSTRUMENTS & SUPPLIES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.